Do you have any queries?

or Call us now at 9982-782-555

;
back-arrow-image Search Health Packages, Tests & More

PDL1 (SP263), IHC

51+ booked in last 3 days

Overview

PD-L1, a key protein in cancer, regulates the immune response. Its overexpression inhibits immune activity, promoting cancer survival. Understanding PD-L1's role aids in understanding cancer mechanisms and developing potential therapeutic strategies.

Read More

PDL1 (SP263), IHC Price

Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the PDL1 (SP263), IHC with a clear pricing structure.

The PDL1 (SP263), IHC Price in Mumbai is ₹ 8,480 .

We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.

Frequently Asked Questions

 

This test measures the levels of the PD-L1 protein in certain types of cancer cells. The PD-L1 protein helps cancer cells evade the immune system, and measuring its levels can help determine the effectiveness of immunotherapy treatment.

  • Assessing the effectiveness of immunotherapy treatment
  • Determining whether a patient will benefit from immunotherapy
  • Identifying patients with certain types of cancer who may respond well to immunotherapy

This test may be recommended if you:

  • Have certain types of cancer, such as lung cancer or melanoma
  • Are undergoing or planning to undergo immunotherapy treatment
  • Want to know if you are likely to respond well to immunotherapy

The test provides a score based on the percentage of cells expressing PD-L1 protein. Higher scores indicate higher levels of PD-L1 expression. Abnormal results may indicate a higher likelihood of responding to immunotherapy treatment, but further discussion with your doctor is needed to interpret the results properly.

  • A small tissue sample will be taken from your tumour
  • The sample is sent to a laboratory for testing
  • The laboratory uses a method called immunohistochemistry (IHC) to measure the levels of PD-L1 protein
  • The results are reported as a score indicating the percentage of cells expressing PD-L1 protein.
  • No specific preparations are required before this test
  • You may be asked to provide your original histopathology report and relevant clinical and radiological details
  • Follow any instructions provided by your doctor or healthcare provider

Other tests that may be ordered alongside the PDL1 (SP263) test include:

  • Genetic testing to identify specific genetic mutations in cancer cells.
  • Complete blood count (CBC) to assess overall health and monitor blood cell levels.
  • Imaging tests such as CT scans or MRIs to evaluate the extent of cancer.

PD-L1 immunohistochemistry test.

Immunotherapy is a type of cancer treatment that helps boost the body's immune system to fight cancer cells. It works by targeting specific proteins or pathways involved in suppressing the immune response, such as PD-L1, allowing the immune system to recognise and attack cancer cells more effectively.

full medical check up

Ratings & Reviews (0)

No reviews available

Why Metropolis?

Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.

We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

lab image
170+ Advanced Labs
lab image
Trusted by Leading Doctors & Hospitals
lab images
Over 2000+ Scientific Officers
reports image
Proficiency Testing for Accurate Reports

Our Blog

Take a look at some of the related content from our blog

Latest Blogs & News

View More
View all